Recombinant tissue plasminogen activator infusion for hemodialysis catheter clearance

Oluwatoyin F. Bamgbola, Marcela Del Rio, Frederick J. Kaskel, Joseph T. Flynn

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Hemodialysis (HD) catheter occlusion is a common cause of poor blood flow and inadequate dialysis. In order to address this problem in our pediatric dialysis unit, we elected to use short (2-h) infusions of low-dose recombinant tissue plasminogen activator (rtPA) for thrombolysis of occluded catheters. Catheters meeting diagnostic criteria for thrombosis were infused with 2.5 mg rtPA in 25 ml 0.9 normal saline over 2 h prior to dialysis. Retrospective data collection was carried out to assess the success of this procedure. Variables assessed included blood flow (Qb), transmembrane pressure (TMP) and venous pressure (VP) before and after rtPA infusion. Seven catheter thromboses in six patients were successfully treated with rtPA; there were significant improvements in Qb (p <0.01), TMP (p <0.01), and VP (p <0.02). At 32 weeks after rtPA therapy, Kaplan-Meier survival analysis showed a 60% probability of primary catheter patency. At the end of the study, 85% of catheters had adequate function as defined by a Qb >200 ml/min. No adverse events were observed. Low-dose rtPA infusion is safe and effective for catheter thrombolysis in outpatient pediatric HD patients. It may serve as an alternative method of administration to local instillation and may be used to restore patency before resorting to surgical revisions.

Original languageEnglish (US)
Pages (from-to)989-993
Number of pages5
JournalPediatric Nephrology
Volume20
Issue number7
DOIs
StatePublished - Jul 2005

Fingerprint

Tissue Plasminogen Activator
Renal Dialysis
Catheters
Dialysis
Thrombosis
Pediatrics
Venous Pressure
Reoperation
Outpatients
Pressure

Keywords

  • Adequacy
  • Adolescents
  • Children
  • Safety
  • Thrombolysis
  • Treatment outcome

ASJC Scopus subject areas

  • Nephrology
  • Pediatrics, Perinatology, and Child Health

Cite this

Recombinant tissue plasminogen activator infusion for hemodialysis catheter clearance. / Bamgbola, Oluwatoyin F.; Del Rio, Marcela; Kaskel, Frederick J.; Flynn, Joseph T.

In: Pediatric Nephrology, Vol. 20, No. 7, 07.2005, p. 989-993.

Research output: Contribution to journalArticle

@article{ac67ade0b9d945e5b57f155ee32b6f08,
title = "Recombinant tissue plasminogen activator infusion for hemodialysis catheter clearance",
abstract = "Hemodialysis (HD) catheter occlusion is a common cause of poor blood flow and inadequate dialysis. In order to address this problem in our pediatric dialysis unit, we elected to use short (2-h) infusions of low-dose recombinant tissue plasminogen activator (rtPA) for thrombolysis of occluded catheters. Catheters meeting diagnostic criteria for thrombosis were infused with 2.5 mg rtPA in 25 ml 0.9 normal saline over 2 h prior to dialysis. Retrospective data collection was carried out to assess the success of this procedure. Variables assessed included blood flow (Qb), transmembrane pressure (TMP) and venous pressure (VP) before and after rtPA infusion. Seven catheter thromboses in six patients were successfully treated with rtPA; there were significant improvements in Qb (p <0.01), TMP (p <0.01), and VP (p <0.02). At 32 weeks after rtPA therapy, Kaplan-Meier survival analysis showed a 60{\%} probability of primary catheter patency. At the end of the study, 85{\%} of catheters had adequate function as defined by a Qb >200 ml/min. No adverse events were observed. Low-dose rtPA infusion is safe and effective for catheter thrombolysis in outpatient pediatric HD patients. It may serve as an alternative method of administration to local instillation and may be used to restore patency before resorting to surgical revisions.",
keywords = "Adequacy, Adolescents, Children, Safety, Thrombolysis, Treatment outcome",
author = "Bamgbola, {Oluwatoyin F.} and {Del Rio}, Marcela and Kaskel, {Frederick J.} and Flynn, {Joseph T.}",
year = "2005",
month = "7",
doi = "10.1007/s00467-004-1797-1",
language = "English (US)",
volume = "20",
pages = "989--993",
journal = "Pediatric Nephrology",
issn = "0931-041X",
publisher = "Springer Verlag",
number = "7",

}

TY - JOUR

T1 - Recombinant tissue plasminogen activator infusion for hemodialysis catheter clearance

AU - Bamgbola, Oluwatoyin F.

AU - Del Rio, Marcela

AU - Kaskel, Frederick J.

AU - Flynn, Joseph T.

PY - 2005/7

Y1 - 2005/7

N2 - Hemodialysis (HD) catheter occlusion is a common cause of poor blood flow and inadequate dialysis. In order to address this problem in our pediatric dialysis unit, we elected to use short (2-h) infusions of low-dose recombinant tissue plasminogen activator (rtPA) for thrombolysis of occluded catheters. Catheters meeting diagnostic criteria for thrombosis were infused with 2.5 mg rtPA in 25 ml 0.9 normal saline over 2 h prior to dialysis. Retrospective data collection was carried out to assess the success of this procedure. Variables assessed included blood flow (Qb), transmembrane pressure (TMP) and venous pressure (VP) before and after rtPA infusion. Seven catheter thromboses in six patients were successfully treated with rtPA; there were significant improvements in Qb (p <0.01), TMP (p <0.01), and VP (p <0.02). At 32 weeks after rtPA therapy, Kaplan-Meier survival analysis showed a 60% probability of primary catheter patency. At the end of the study, 85% of catheters had adequate function as defined by a Qb >200 ml/min. No adverse events were observed. Low-dose rtPA infusion is safe and effective for catheter thrombolysis in outpatient pediatric HD patients. It may serve as an alternative method of administration to local instillation and may be used to restore patency before resorting to surgical revisions.

AB - Hemodialysis (HD) catheter occlusion is a common cause of poor blood flow and inadequate dialysis. In order to address this problem in our pediatric dialysis unit, we elected to use short (2-h) infusions of low-dose recombinant tissue plasminogen activator (rtPA) for thrombolysis of occluded catheters. Catheters meeting diagnostic criteria for thrombosis were infused with 2.5 mg rtPA in 25 ml 0.9 normal saline over 2 h prior to dialysis. Retrospective data collection was carried out to assess the success of this procedure. Variables assessed included blood flow (Qb), transmembrane pressure (TMP) and venous pressure (VP) before and after rtPA infusion. Seven catheter thromboses in six patients were successfully treated with rtPA; there were significant improvements in Qb (p <0.01), TMP (p <0.01), and VP (p <0.02). At 32 weeks after rtPA therapy, Kaplan-Meier survival analysis showed a 60% probability of primary catheter patency. At the end of the study, 85% of catheters had adequate function as defined by a Qb >200 ml/min. No adverse events were observed. Low-dose rtPA infusion is safe and effective for catheter thrombolysis in outpatient pediatric HD patients. It may serve as an alternative method of administration to local instillation and may be used to restore patency before resorting to surgical revisions.

KW - Adequacy

KW - Adolescents

KW - Children

KW - Safety

KW - Thrombolysis

KW - Treatment outcome

UR - http://www.scopus.com/inward/record.url?scp=21344472135&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21344472135&partnerID=8YFLogxK

U2 - 10.1007/s00467-004-1797-1

DO - 10.1007/s00467-004-1797-1

M3 - Article

C2 - 15843999

AN - SCOPUS:21344472135

VL - 20

SP - 989

EP - 993

JO - Pediatric Nephrology

JF - Pediatric Nephrology

SN - 0931-041X

IS - 7

ER -